Diabetes drug may be game changer
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Getting a grip on diabetes: Aptitude device gets fast track status for clinical trials
Aptitude creates a special type of molecule called an aptamer, which it is using to develop a first-of-its-kind hand-held device that measures insulin concentrations in real-time and can diagnose pre-diabetes. The government’s interest in furthering such research is unsurprising as diabetes affects more than 9 percent of Americans.
Read More →A heartbeat away: Advances in diabetes tech promise better self-care
In May 1922, Dr. William Sansum injected a diabetes patient with insulin for the first time in the U.S., instantly increasing life expectancy from mere weeks to many years. His patient lived to 90.
Read More →Active Life device finds link between diabetes, bone issues
A device made by Santa Barbara-based Active Life Scientific played a critical role in a new study at the Mayo Clinic linking Type 2 diabetes to bone problems.
Read More →Study targets diabetes
New research conducted on the South Coast could point the way to the prevention and cure of type two diabetes.
Read More →
Sponsored content:
2015-2016 Giving Guide
